LÉVÉTIRACETAM BEKER ®

Levetiracetam BEKER® is an antiepileptic drug. It is indicated as monotherapy for the treatment of partial seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy; or dual therapy as indicated on the package leaflet.

Additional information

DCI

LEVETIRACETAM

Dosage

500 mg

Trade name

LÉVÉTIRACETAM BEKER ®

Name of the originator

KEPPRA

Presentation

60 tablets

Specialty

Psychiatrie – Antiépileptique

See also